Hepatitis testing is essential to diagnose different types of hepatitis viruses, which can cause liver inflammation and serious health issues if not promptly treated. Testing involves blood tests to detect antibodies or antigens, with additional tests sometimes needed to assess liver damage. Individuals with risk factors should undergo testing, as early detection can help prevent complications and ensure proper treatment. If exposed or experiencing symptoms, seek medical evaluation for treatment options such as antiviral medications and monitoring of liver function.
Sort by title | Sort by title | Sort by price | Sort by price
The Hepatitis A Antibody Test, IgM is a blood test that detects the presence of IgM antibodies specific to the Hepatitis A virus. IgM antibodies are produced by the immune system in response to a recent infection, so a positive result indicates a current or recent Hepatitis A infection. This test is typically used to diagnose acute Hepatitis A infection or to confirm a suspected case of Hepatitis A.
Hepatitis A immunity testing is a blood test used to check if antibodies are present against the hepatitis A virus, indicating prior infection or vaccination. It is advisable for individuals at risk of hepatitis A exposure, like healthcare workers, travelers to affected regions, or those with liver issues. This testing helps in making vaccination and preventive care decisions for hepatitis A protection.
Hepatitis A, B, and C panel consists of blood tests used to detect and diagnose infections with these three hepatitis viruses that affect the liver. The panel includes tests for antibodies and antigens related to each virus, helping healthcare providers diagnose and manage patients with hepatitis infections. Treatment for hepatitis A, B, and C infections may include antiviral medications, supportive care, and vaccination for prevention. Consulting a healthcare provider for proper evaluation and management of hepatitis infections is crucial.
The Hepatitis A, B, & C Antibodies Confirmation Panel is a blood test designed to identify antibodies against the hepatitis A, B, and C viruses, revealing past exposure and aiding in determining immunity or active infection. Healthcare providers commonly order this panel to diagnose and oversee cases of hepatitis infections.
The Hepatitis B Core Antibody Test, IgM is a blood test that detects IgM antibodies to the hepatitis B core antigen, indicating recent or ongoing infection with the hepatitis B virus. While a positive result suggests acute hepatitis B infection, further testing like the Hepatitis B Surface Antigen test is required for a complete diagnosis and treatment plan.
A Hepatitis B Immunity Status Test is a blood test that checks for antibodies to the hepatitis B virus, to determine if a person is immune due to infection or vaccination. It helps healthcare providers assess the risk of hepatitis B and decide on vaccination needs.
The HBsAg test is a blood test used to detect hepatitis B virus. It is part of routine blood work, helps monitor chronic infections, and identifies carriers. A positive result shows current infection, prompting further tests to determine severity and treatment. Consult a healthcare provider for result interpretation and treatment to prevent liver damage and complications like cirrhosis and cancer.
The HCV antibody test detects antibodies in response to the Hepatitis C virus. A positive result indicates past exposure. Further tests may be needed to confirm active infection. Untreated chronic Hepatitis C can lead to liver damage and cancer. Those at risk should get tested regularly for early detection and prevention of complications.
The HCV RNA test is used to detect the presence of hepatitis C virus in the blood by measuring the amount of viral RNA. It confirms infection, monitors treatment effectiveness, and checks for recurrence. Results indicate viral load, guiding treatment decisions. A healthcare provider should interpret results for discussing potential treatment options post-test.
USLABTESTING